Navigation Links
Cleveland Clinic Recognizes Circulating Tumor Cell Technology as Top Medical Innovation for 2009
Date:11/12/2008

ll through this innovative technology provides physicians with an important measure of a patient's disease prognosis to help them make more informed patient care decisions. Dr. Mark Graham, a practicing oncologist from Waverly Hematology Oncology in Cary, North Carolina, has used CellSearch(R) for the past two years to regularly monitor the prognosis of his population of metastatic breast cancer patients.

"Knowing a patient's CTC count provides a second measurement, complementary to traditional imaging, to help me assess the prognosis of a patient and gauge her response to current treatment. This allows my team to better advise patients of their current status and make more informed treatment decisions. Many of my patients find that the CellSearch(R) CTC test allows them to continue their daily activities with the peace of mind that I am closely monitoring their disease and will be able to adjust their treatment in a timely fashion, if necessary," says Dr. Graham.

Dr. Graham adds, "Our general impression is that the CellSearch(R) test has allowed us to do fewer radiology imaging studies, which can reduce cost, lessen radiation exposure and save valuable time for the patient."

Last year, another Veridex diagnostic test, the GeneSearch(TM) Breast Lymph Node Assay, was recognized by TIME magazine as one of the top medical breakthroughs of 2007. This assay is a diagnostic test indicated to detect lymph node metastases in breast cancer.

About CellSearch(R)

The CellSearch(R) test works by using antibodies that are joined to microscopic iron particles, called ferrofluid. These antibody/ferrofluid combinations attach very specifically to CTCs. Powerful magnets then draw the CTCs out of the blood sample and they are then stained with additional bio-molecules and chemicals so that they can be positively identified as CTCs.

About Veridex, LLC

Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing ph
'/>"/>

SOURCE Veridex, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NanoMedicine Summit Returns to Cleveland, September 25-26
2. University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
3. Cleveland Clinic and Rutgers to Lead Newly Formed Institute for War Wounded
4. Siemens Signs Multi-Year Agreement With Cleveland Clinic to Deploy Enterprise-Wide Cardiology PACS
5. Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007
6. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
7. Metabolex Announces Positive Results From Phase 1a Clinical Trial of MBX-2982
8. Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans
9. CorMatrix Announces Pre-Clinical Data Suggesting Next Generation ECM Technology(TM) Can Improve Cardiac Function
10. Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
11. Potentia Pharmaceuticals Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 19, 2014 BioPlus Specialty ... pharmacies, announces the promotion of Nick Maroulis, Pharm.D. to ... Pharmacy Services. , In this position, Dr. Maroulis ... also managing the directors of our multi-site pharmacies as ... since 1997 and during that time he has served ...
(Date:12/19/2014)... , Dec. 19, 2014  Roche (SIX: RO, ... Bina Technologies, Inc. (Bina), a privately held company ... , USA. Bina provides a big data platform ... sequencing (NGS) data. Bina,s proprietary on-market Genomic Management ... academic researchers to perform fast and scalable analyses ...
(Date:12/19/2014)... 2014 Decision Resources Group finds that the ... 12 percent compound annual growth rate through 2023. This ... and the increasing adoption of dental implants. Growing aesthetic ... also spur demand for dental biomaterials because they can ... treatments. Other key findings from Decision Resources ...
(Date:12/19/2014)... Altamonte Springs, FL (PRWEB) December 18, 2014 ... one of the nation’s leading specialty pharmacies, has ... who serve as clinical pharmacy consultants for prescriber ... disease therapy expertise. , “We have a ... disease therapies. For example, those specializing in hepatitis ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3
... Institutional Private Placement -, - $10 Million Principal Amount of Debt ... ... Stock -, DALLAS, Nov. 8 Access Pharmaceuticals, ... a $19.5 million recapitalization. The Company has entered,into agreements with institutional ...
... announced,the addition of Mr. Robert A. Ingram as Special ... and the hiring of Mr. Marty Glick as Executive ... Pharmaceuticals at GlaxoSmithKline (plc),and previously served as Chief Executive ... Glaxo Wellcome. Mr. Ingram,is Chairman of the Board of ...
... --,Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT),announced ... were $6,214,712,an increase of 567% over $930,442 in the ... third quarter of 2007 were $2,957,972 an increase of,226% ... These significant,increases are due to the growth of Kiwa,s ...
Cached Biology Technology:Access Pharmaceuticals Announces $19.5 Million Recapitalization 2Access Pharmaceuticals Announces $19.5 Million Recapitalization 3Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy 2Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 2Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 3Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 4Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 5Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 6Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 7Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 8Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 9
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal ... that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four ... has served as a meeting place for peoples ... and the ongoing mixing of peoples with African, European, ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... ARTICLE #1 FOR IMMEDIATE RELEASE Lead leaching ... Science & Technology Scientists in Virginia are ... (PVC) plastic pipes may be more susceptible to leaching ... types of piping especially when PVC systems include ...
... June 2, 2008 UT Southwestern Medical Center ... pancreatic beta cells can regenerate after being induced to ... future insights into improved treatments of diabetes, which affects ... mouse, mimics what occurs in humans with type 1 ...
... already imperiled sturgeons, more caviar will be exported from ... a result of unacceptably permissive new trade quotas announced ... Species (CITES). Most sturgeon species are endangered and some, ... will further damage this ancient fish,s chance of recovery ...
Cached Biology News:American Chemical Society's Weekly PressPac -- May 28, 2008 2American Chemical Society's Weekly PressPac -- May 28, 2008 3American Chemical Society's Weekly PressPac -- May 28, 2008 4American Chemical Society's Weekly PressPac -- May 28, 2008 5American Chemical Society's Weekly PressPac -- May 28, 2008 6American Chemical Society's Weekly PressPac -- May 28, 2008 7Mouse model developed at UT Southwestern mimics hyperglycemia, aids in diabetes research 2Mouse model developed at UT Southwestern mimics hyperglycemia, aids in diabetes research 3New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 2New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 3New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 4
Pronase Reagent...
Rabbit polyclonal to ECSIT ( Abpromise for all tested applications). entrezGeneID: 51295 SwissProtID: Q96HQ7...
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide...
Raised to arginine vasopressin coupled to bovine thyroglobulin with carbodiimide ....
Biology Products: